Pyxis Oncology Inc (PYXS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $188.98M
Last updated: Nov 17, 2026 at 11:05 AM ET
Pyxis Oncology Inc (PYXS) Earnings: Report Dates and Results
Pyxis Oncology (PYXS) is expected to report earnings on Mar 22, 2027. In the quarter ended Sep 30, 2026, Pyxis Oncology reported EPS of -$0.24, above the -$0.27 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
PYXS has an expected report date of Mar 22, 2027.
Earnings History
Of the 21 quarters below that had an estimate, PYXS beat 11 and missed 10. The widest gap in the table came in the quarter ended Dec 31, 2021, when EPS landed 435.14% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.24 | -$0.27 | -$0.36 - -$0.22 | +11.11% | Beat | N/A | 9 | N/A | Nov 5, 2026 | N/A |
| Jun 30, 2026 | -$0.40 | -$0.34 | -$0.40 - -$0.29 | -17.65% | Miss | N/A | 9 | 1 up, 1 down | Aug 13, 2026 | $389000 |
| Mar 31, 2026 | -$0.37 | -$0.35 | -$0.42 - -$0.29 | -5.71% | Miss | N/A | 9 | 2 up, 3 down | May 14, 2026 | $631000 |
| Dec 31, 2025 | -$0.29 | -$0.33 | -$0.39 - -$0.29 | +11.83% | Beat | N/A | 9 | 1 up, 6 down | Mar 23, 2026 | $9.15M |
| Sep 30, 2025 | -$0.35 | -$0.34 | -$0.37 - -$0.27 | -2.94% | Miss | N/A | 7 | 4 up, 2 down | Nov 3, 2025 | $684000 |
| Jun 30, 2025 | -$0.30 | -$0.35 | -$0.36 - -$0.34 | +14.29% | Beat | N/A | 6 | 0 up, 3 down | Aug 14, 2025 | $2.82M |
| Mar 31, 2025 | -$0.35 | -$0.29 | -$0.32 - -$0.26 | -20.69% | Miss | N/A | 3 | 0 up, 0 down | May 15, 2025 | $515000 |
| Dec 31, 2024 | -$1.32 | -$0.32 | -$0.38 - -$0.28 | -312.50% | Miss | N/A | 7 | 1 up, 4 down | Mar 18, 2025 | N/A |
| Sep 30, 2024 | -$0.35 | -$0.31 | -$0.35 - -$0.29 | -12.90% | Miss | N/A | 6 | 0 up, 0 down | Nov 12, 2024 | $705000 |
| Jun 30, 2024 | -$0.29 | -$0.33 | -$0.37 - -$0.27 | +12.12% | Beat | N/A | 7 | 0 up, 0 down | Aug 14, 2024 | $708000 |
| Mar 31, 2024 | -$0.06 | -$0.24 | -$0.34 - -$0.12 | +75.00% | Beat | N/A | 6 | 0 up, 0 down | May 14, 2024 | $16.95M |
| Dec 31, 2023 | -$0.33 | -$0.47 | -$0.57 - -$0.35 | +29.79% | Beat | N/A | 6 | 0 up, 0 down | Mar 21, 2024 | $576000 |
| Sep 30, 2023 | -$0.56 | -$0.51 | -$0.63 - -$0.44 | -9.80% | Miss | N/A | 3 | 0 up, 0 down | Nov 7, 2023 | $598000 |
| Jun 30, 2023 | -$0.41 | -$0.66 | -$0.74 - -$0.61 | +37.88% | Beat | N/A | 4 | 0 up, 0 down | Aug 11, 2023 | $564000 |
| Mar 31, 2023 | -$0.55 | -$0.90 | -$1.08 - -$0.79 | +38.89% | Beat | N/A | 4 | 0 up, 0 down | May 11, 2023 | $38000 |
| Dec 31, 2022 | -$1.04 | -$1.01 | -$1.17 - -$0.81 | -2.97% | Miss | N/A | 4 | 0 up, 0 down | Mar 22, 2023 | N/A |
| Sep 30, 2022 | -$0.85 | -$0.89 | -$0.96 - -$0.67 | +4.49% | Beat | N/A | 4 | 0 up, 0 down | Nov 1, 2022 | N/A |
| Jun 30, 2022 | -$0.79 | -$0.92 | -$1.00 - -$0.51 | +14.13% | Beat | N/A | 4 | 0 up, 0 down | Aug 15, 2022 | N/A |
| Mar 31, 2022 | -$0.97 | -$0.50 | -$0.73 - -$0.43 | -94.00% | Miss | N/A | 4 | 0 up, 0 down | May 13, 2022 | N/A |
| Dec 31, 2021 | -$1.98 | -$0.37 | -$0.54 - -$0.37 | -435.14% | Miss | N/A | 4 | 0 up, 1 down | Mar 29, 2022 | N/A |
| Sep 30, 2021 | -$0.45 | -$0.52 | -$8.97 - -$0.23 | +13.46% | Beat | N/A | 4 | N/A | Oct 8, 2021 | N/A |
| Jun 30, 2021 | -$1.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 1, 2021 | N/A |
| Mar 31, 2021 | -$15.93 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 30, 2021 | N/A |
| Dec 31, 2020 | -$15.93 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2021 | N/A |
| Mar 31, 2020 | -$2.74 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 29, 2020 | N/A |
| Dec 31, 2019 | -$2.74 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2020 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.29, after -$2.02 the year before. It was -$2.74 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.29 | N/A |
| Dec 31, 2024 | -$2.02 | N/A |
| Dec 31, 2023 | -$1.85 | N/A |
| Dec 31, 2022 | -$3.65 | N/A |
| Dec 31, 2021 | -$19.38 | N/A |
| Dec 31, 2020 | -$18.67 | N/A |
| Dec 31, 2019 | -$2.74 | N/A |
Frequently Asked Questions About PYXS
When is Pyxis Oncology's next earnings date?
Pyxis Oncology's next earnings report is expected for Mar 22, 2027.
Did PYXS beat earnings estimates last quarter?
Yes. Pyxis Oncology reported EPS of -$0.24 for the quarter ended Sep 30, 2026, above the -$0.27 estimate, a 11.11% surprise.
What EPS do analysts expect from PYXS next quarter?
The consensus EPS estimate for Pyxis Oncology for the quarter ending Dec 31, 2026 is -$0.23 from 11 analysts, with estimates from -$0.30 to -$0.16.
How often does PYXS beat earnings estimates?
Pyxis Oncology beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -40.28%.
PYXS pages: Overview, Earnings, Forecast, Financials, Competitors